James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $557.85 ($5.6M) on 2026-05-21, disclosed to the SEC on 2026-05-22.
Scheduled sale ($5.6M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $557.85 | 40 | $22K | 0.4% |
| 2 | $560.03 | 320 | $179K | 3.2% |
| 3 | $562.01 | 920 | $517K | 9.2% |
| 4 | $563.12 | 2,677 | $1.5M | 26.7% |
| 5 | $564.10 | 2,081 | $1.2M | 20.8% |
| 6 | $565.10 | 1,765 |
| $997K |
| 17.7% |
| 7 | $566.12 | 2,197 | $1.2M | 22.0% |
| Total | $564.11 avg | 10,000 | $5.6M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |